Cathy Eng: Role of ctDNA in resected liver metastasis in colorectal cancer by Koshi Kataoka et. al
Cathy Eng, Co-Leader of the Gastrointestinal Cancer Research Program at the Vanderbilt-Ingram Cancer Center, posted on X:
“Glad to see this data out from our colleagues in Japan, Dr. Kataoka.
Galaxy trial re: role of ctDNA in resected liver metastasis colorectal cancer and the benefit of adjuvant chemo in (+) MRD patients for OS.”
Cathy Eng is a Professor of Medicine, Hematology and Oncology, and is the Co-Director of GI Oncology, Associate Director of Strategic Relations and Research Partners and Co-Leader of the Gastrointestinal Cancer Research Program at the Vanderbilt-Ingram Cancer Center. She also holds the David H. Johnson Endowed Chair of Surgical and Medical Oncology. Dr. Eng was previously a Professor of Medical Oncology at The University of Texas MD Anderson Cancer Center.
Her primary clinical research interests include clinical trials involving innovative drugs for the treatment of colorectal, anal, and appendiceal cancers. She has a specific interest in young colorectal cancer patients as well as the role of immunotherapy in HPV-associated cancers. Nationally, Dr. Eng has served in multiple leadership roles for ASCO, ASCO GI, ECOG, and the NCI Rectal/Anal Task Force. She has most recently been chosen to serve as the Vice-Chair for the SWOG GI Committee and the NCI GI Steering Committee.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023